nivolumab,oxaliplatin
bms
['metimmox']
five norwegian oncology centers participated in the metimmox-1 study. cordially grateful to all of the investigators and their teams, each of the patients and their caregivers, and to the funder 
Professor of Oncology. Clinical Oncologist. Research Group Leader. Univ Oslo @UniOslo_MED Akershus Univ Hosp @Ahus_no Opinions personal